Progestagens and anti-progestagens for pain associated with endometriosis.

作者: Julie Brown , Sari Kives , Muhammad Akhtar

DOI: 10.1002/14651858.CD002122.PUB2

关键词:

摘要: Background Endometriosis is a chronic inflammatory condition defined by the presence of glands and stroma outside uterine cavity. It occurs in 7% to 10% all women reproductive age may present as pain or infertility. The pelvic be form dysmenorrhoea, dyspareunia pain. Initially combination estrogens progestagens was used create pseudopregnancy alleviate symptoms associated with endometriosis. Progestagens alone anti-progestagens have been considered alternatives because they are inexpensive better side effect profile than other choices. Objectives To determine effectiveness both treatment painful ascribed diagnosis endometriosis. Search methods We search strategy Menstrual Disorders Subfertility Group identify publications which described might randomised controlled trials (RCTs) any progestagen anti-progestagen symptomatic We updated review 2011. Selection criteria We only RCTs compared use interventions, placebo no for alleviation endometriosis. Data collection analysis We added six new studies, bringing total included studies 13 update this review. newly evaluated (comparisons placebo, danazol, oral subdermal contraceptive, contraceptive pill gonadotrophin-releasing hormone (GnRH) analogue drugs). remaining gestrinone GnRH analogues itself. Main results The medroxyprogesterone acetate (100 mg daily) appeared more effective at reducing up 12 months follow-up (MD -0.70, 95% CI -8.61 -5.39; P < 0.00001) placebo. There evidence significantly cases acne (six versus one) oedema (11 group difference objective efficacy between dydrogesterone placebo. There benefit depot administration treatments (low dose leuprolide acetate) reduced symptoms. experienced adverse effects. There overall over medical self-reported efficacy. Amenorrhoea bleeding were frequently reported groups. There (gestrinone) danazol. (leuprorelin) found improve dysmenorrhoea 0.82, 0.15 1.49; = 0.02) although it also increased hot flushes (OR 0.20, 0.06 -0.63; 0.006). Authors' conclusions There limited support

参考文章(50)
Wheeler Jm, Epidemiology of endometriosis-associated infertility. Journal of Reproductive Medicine. ,vol. 34, pp. 41- 46 ,(1989)
Luigi Fedele, Stefano Bianchi, Tiziana Viezzoli, Luisa Arcaini, Giovanni B. Candiani, Gestrinone versus danazol in the treatment of endometriosis. Fertility and Sterility. ,vol. 51, pp. 781- 785 ,(1989) , 10.1016/S0015-0282(16)60666-0
J Moore, S Kennedy, A Prentice, Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database of Systematic Reviews. ,(1997) , 10.1002/14651858.CD001019
Tasuku Harada, Mikio Momoeda, Yuji Taketani, Takeshi Aso, Masao Fukunaga, Hiroshi Hagino, Naoki Terakawa, Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial Fertility and Sterility. ,vol. 91, pp. 675- 681 ,(2009) , 10.1016/J.FERTNSTERT.2007.12.080
T. Faustmann, C. Seitz, J. Marr, C. Gerlinger, T. Strowitzki, O301 Safety of dienogest for the treatment of endometriosis: A 24-week, randomised, open-label trial versus leuprolide acetate International Journal of Gynecology & Obstetrics. ,vol. 107, pp. S179- S179 ,(2009) , 10.1016/S0020-7292(09)60673-1
P. A. Regidor, M. Regidor, M. Schmidt, B. Ruwe, G. Lübben, P. Förtig, E. Kienle, A. E. Schindler, Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis. Gynecological Endocrinology. ,vol. 15, pp. 202- 209 ,(2001) , 10.1080/GYE.15.3.202.209
H. W. Halbe, M. S. Nakamura, G. P. G. Silveira, W. P. C. Carvalho, Updating the clinical experience in endometriosis – the Brazilian perspective British Journal of Obstetrics and Gynaecology. ,vol. 102, pp. 17- 21 ,(1995) , 10.1111/J.1471-0528.1995.TB09161.X
Katharina Walch, Gertrud Unfried, Johannes Huber, Christine Kurz, Michael van Trotsenburg, Elisabeth Pernicka, René Wenzl, Implanon® versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis — a pilot study Contraception. ,vol. 79, pp. 29- 34 ,(2009) , 10.1016/J.CONTRACEPTION.2008.07.017